LOVELACE BIOMEDICAL RESEARCH INSTITUTE: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: MBT9RXJJ7428
33contracts won
$95,864,962total obligated
$1,251,731median contract
Sep 28, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 32 | $95,123,111 |
| Department of Defense | 1 | $741,851 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541380 Testing Laboratories and Services | 3 | $45,888,363 |
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 15 | $19,407,827 |
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 8 | $13,500,293 |
| 541690 Other Scientific and Technical Consulting Services | 4 | $10,272,019 |
| 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) | 1 | $5,298,497 |
| 541711 Research and development in biotechnology | 1 | $756,111 |
| 511210 Software publishers | 1 | $741,851 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| GLP REPEAT DOSE TOXICOLOGY STUDY FOR A LIVE-ATTENUATED RESPIRATORY VIRUS VACCINE.
75N98026F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Rockville, MD |
— | Department of Health and Human Services National Institutes of Health |
$339,534 | Sep 28, 2026 Ends: Mar 27, 2027 |
| NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY
75F40126F19003 · NAICS 541690 Other Scientific and Technical Consulting Services · Beltsville, MD |
— | Department of Health and Human Services Food and Drug Administration |
$3,017,553 | Sep 14, 2026 Ends: Sep 13, 2030 |
| RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
75A50126F61002 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Albuquerque, NM |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$3,723,027 | Aug 26, 2026 Ends: Apr 25, 2028 |
| SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).
75F40125P00216 · NAICS 541380 Testing Laboratories and Services · Albuquerque, NM |
— | Department of Health and Human Services Food and Drug Administration |
$7,058,882 | Sep 19, 2025 Ends: Sep 29, 2027 |
| 24-015894 NHLBI POPULATION SCIENCES BRANCH REQUIRES PULMONARY FUNCTION TESTING TO DETERMINE IF THE FLEXIVENT METHOD OF PULMONARY FUNCTION TE…
75N92024P00303 · NAICS 541380 Testing Laboratories and Services · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$16,653 | Sep 10, 2024 Ends: Nov 15, 2024 |
| EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH 20, 2025.
75N95024F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$140,848 | Mar 21, 2024 Ends: Apr 28, 2025 |
| RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5. PERIOD …
75N95024F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$211,128 | Mar 21, 2024 Ends: Apr 23, 2025 |
| RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RAB…
75A50123F61001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Albuquerque, NM |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$5,905,018 Potential value: $8,829,095 |
Sep 29, 2023 Ends: Apr 17, 2027 |
| TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR
75F40123F19002 · NAICS 541690 Other Scientific and Technical Consulting Services · Beltsville, MD |
— | Department of Health and Human Services Food and Drug Administration |
$1,251,731 | Sep 29, 2023 Ends: Sep 29, 2027 |
| EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY M…
75N95023F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$1,899,147 Potential value: $4,024,027 |
Sep 29, 2023 Ends: Jun 30, 2028 |
| TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHI…
75F40123F19001 · NAICS 541690 Other Scientific and Technical Consulting Services · Beltsville, MD |
— | Department of Health and Human Services Food and Drug Administration |
$3,872,713 | Sep 27, 2023 Ends: Apr 18, 2025 |
| GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY
75N92023F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$171,742 | Sep 25, 2023 Ends: Jun 30, 2024 |
| CHARACTERIZATION OF SPONTANEOUS OSTEOGENESIS AFTER SURGICAL SEGMENTAL BONE DEFECT IN A LARGE ANIMAL
75N95023F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$385,704 | Aug 07, 2023 Ends: Nov 07, 2024 |
| BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
75A50123F61001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Albuquerque, NM |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$100,283 | Jul 20, 2023 Ends: Jul 19, 2027 |
| ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. …
75N95022F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$148,800 | Sep 26, 2022 Ends: Sep 30, 2024 |
| ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. …
75N95022F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$162,965 | Sep 26, 2022 Ends: Sep 30, 2024 |
| CTP-2022-111127 - SALTS
75F40122F19001 · NAICS 541690 Other Scientific and Technical Consulting Services · Silver Spring, MD |
— | Department of Health and Human Services Food and Drug Administration |
$2,130,022 | Sep 22, 2022 Ends: Feb 22, 2027 |
| LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.
W81XWH22P0157 · NAICS 511210 Software publishers · Silver Spring, MD |
— | Department of Defense Defense Health Agency |
$741,851 Potential value: $1,273,832 |
Sep 16, 2022 Ends: Sep 19, 2027 |
| GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY
75N92022F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$1,143,792 | Sep 09, 2022 Ends: Jun 30, 2024 |
| BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS
75N95022F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$792,052 | Jun 17, 2022 Ends: Jun 30, 2025 |
| SUPPORT NON-CLINICAL IMMUNOGENICITY STUDIES OF SARS-COV-2 MICRONEEDLE PATCH VACCINES CANDIDATES IN A SMALL-ANIMAL MODEL
75A50122F61001 · NAICS 541711 Research and development in biotechnology · Albuquerque, NM |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$756,111 | Mar 08, 2022 Ends: Dec 07, 2023 |
| THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGE…
75N93022F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$680,219 | Nov 15, 2021 Ends: Apr 15, 2026 |
| EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL A…
75N95021F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$452,931 | Sep 29, 2021 Ends: May 31, 2026 |
| CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN
75N95021F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$1,633,884 Potential value: $2,011,289 |
Sep 24, 2021 Ends: Jun 30, 2027 |
| GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY/TOXICOLOGY CORE LABORATORY - SCIENTIFIC PROJECT FOR RSA NO. 2057 (RADER)
75N92021F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Albuquerque, NM |
— | Department of Health and Human Services National Institutes of Health |
$1,609,194 | Sep 08, 2021 Ends: Jun 30, 2024 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.